ArticleClinical ophthalmology (Auckland, N.Z.)2022

A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The "ELEVATE" Study.

Alexandros Rouvas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.